Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 3/g
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Protionamide |
Appearance | Yellow Powder |
CAS NO. | 14222-60-7 |
MF | C9H12N2S |
Storage | Keep in a cool, dry, dark location |
Protionamide is a synthetic chemical compound primarily used in medical treatment, specifically as an antimicrobial agent. It belongs to the category of drugs known as anti-tubercular agents, which are crucial in the management of tuberculosis. Chemically, it is a derivative of isonicotinamide, exhibiting similar pharmacological properties but with distinct pharmacokinetic characteristics.
Tuberculosis Treatment: Protionamide is primarily prescribed as part of combination therapy for tuberculosis. It works synergistically with other anti-tubercular drugs to enhance treatment efficacy and reduce the risk of drug resistance.
Combination Therapy: Due to its unique mechanism of action, protionamide is often included in multidrug regimens to target different stages of the tuberculosis infection, ensuring comprehensive coverage against the Mycobacterium tuberculosis bacterium.
Adjuvant Therapy: In some cases, it may be used as an adjuvant therapy in combination with other medications to manage specific types of tuberculosis infections that are resistant to standard treatments.
Bacterial Inhibition: Protionamide functions by inhibiting the synthesis of mycobacterial proteins, which are essential for the survival and replication of Mycobacterium tuberculosis. This leads to the suppression of bacterial growth and, eventually, eradication of the infection.
Enhancing Immune Response: By reducing the bacterial load, protionamide helps to alleviate the immune response triggered by tuberculosis, thereby mitigating the inflammatory damage caused by the infection.
Improving Drug Efficacy: Its inclusion in combination therapies enhances the overall effectiveness of the treatment regimen, reducing the duration of treatment and the likelihood of recurrence.